349 related articles for article (PubMed ID: 17847121)
1. Simultaneous versus sequential pharmacokinetic-pharmacodynamic population analysis using an iterative two-stage Bayesian technique.
Proost JH; Schiere S; Eleveld DJ; Wierda JM
Biopharm Drug Dispos; 2007 Nov; 28(8):455-73. PubMed ID: 17847121
[TBL] [Abstract][Full Text] [Related]
2. Performance of an iterative two-stage bayesian technique for population pharmacokinetic analysis of rich data sets.
Proost JH; Eleveld DJ
Pharm Res; 2006 Dec; 23(12):2748-59. PubMed ID: 17089202
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic-pharmacodynamic model for educational simulations.
van Meurs WL; Nikkelen E; Good ML
IEEE Trans Biomed Eng; 1998 May; 45(5):582-90. PubMed ID: 9581056
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children.
Woloszczuk-Gebicka B; Wyska E; Grabowski T; Swierczewska A; Sawicka R
Paediatr Anaesth; 2006 Jul; 16(7):761-8. PubMed ID: 16879519
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the nonparametric estimation method in NONMEM VI.
Savic RM; Kjellsson MC; Karlsson MO
Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic parameters estimation using adaptive Bayesian P-splines models.
Jullion A; Lambert P; Beck B; Vandenhende F
Pharm Stat; 2009; 8(2):98-112. PubMed ID: 18481279
[TBL] [Abstract][Full Text] [Related]
7. A Bayesian population PK-PD model of ispinesib-induced myelosuppression.
Kathman SJ; Williams DH; Hodge JP; Dar M
Clin Pharmacol Ther; 2007 Jan; 81(1):88-94. PubMed ID: 17186004
[TBL] [Abstract][Full Text] [Related]
8. Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients.
Calvo R; Telletxea S; Leal N; Aguilera L; Suarez E; De La Fuente L; Martin-Suarez A; Lukas JC
Acta Anaesthesiol Scand; 2004 Sep; 48(8):1038-48. PubMed ID: 15315624
[TBL] [Abstract][Full Text] [Related]
9. [Using CTS and PK-PD models to predict the effect of uncertainty about population parameters on clinical trial power].
Zhu L; Shi X; Liu Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Feb; 26(1):42-6, 62. PubMed ID: 19334551
[TBL] [Abstract][Full Text] [Related]
10. Population one-compartment pharmacokinetic analysis with missing dosage data.
Soy D; Beal SL; Sheiner LB
Clin Pharmacol Ther; 2004 Nov; 76(5):441-51. PubMed ID: 15536459
[TBL] [Abstract][Full Text] [Related]
11. Development of an optimal sampling strategy for clinical pharmacokinetic studies of the novel anthracycline disaccharide analogue MEN-10755.
Bos AM; Boom K; Vinks AA; Boezen HM; Wanders J; Dombernovsky P; Aamdal S; de Vries EG; Uges DR
Cancer Chemother Pharmacol; 2004 Jul; 54(1):64-70. PubMed ID: 15069581
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic analysis of amikacin and validation on neonates using Monte Carlo method.
Wang J; Liang WQ; Wu JJ; Pan CM
Acta Pharmacol Sin; 2000 Oct; 21(10):954-60. PubMed ID: 11501052
[TBL] [Abstract][Full Text] [Related]
13. [Population pharmacokinetic model for gentamycin and its predictive value].
Wang J; Liang WQ
Yao Xue Xue Bao; 2001 Sep; 36(9):703-6. PubMed ID: 12580113
[TBL] [Abstract][Full Text] [Related]
14. A Bayesian approach for PK/PD modeling with PD data below limit of quantification.
Zhou H; Hartford A; Tsai K
J Biopharm Stat; 2012; 22(6):1220-43. PubMed ID: 23075019
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous vs. sequential analysis for population PK/PD data II: robustness of methods.
Zhang L; Beal SL; Sheinerz LB
J Pharmacokinet Pharmacodyn; 2003 Dec; 30(6):405-16. PubMed ID: 15000422
[TBL] [Abstract][Full Text] [Related]
16. [Can we use a Bayesian method to build a pharmacokinetic population in two steps?].
Cabelguenne D; Bleyzac N; Pivot C; Maire P
Therapie; 2000; 55(2):277-82. PubMed ID: 10967700
[TBL] [Abstract][Full Text] [Related]
17. Drug-drug interaction prediction: a Bayesian meta-analysis approach.
Li L; Yu M; Chin R; Lucksiri A; Flockhart DA; Hall SD
Stat Med; 2007 Sep; 26(20):3700-21. PubMed ID: 17357990
[TBL] [Abstract][Full Text] [Related]
18. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.
Woloszczuk-Gebicka B; Wyska E; Grabowski T
Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645
[TBL] [Abstract][Full Text] [Related]
19. Performance of different population pharmacokinetic algorithms.
Colucci P; Grenier J; Yue CS; Turgeon J; Ducharme MP
Ther Drug Monit; 2011 Oct; 33(5):583-91. PubMed ID: 21912327
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic target attainment analysis of doripenem in infected patients.
Ikawa K; Morikawa N; Uehara S; Monden K; Yamada Y; Honda N; Kumon H
Int J Antimicrob Agents; 2009 Mar; 33(3):276-9. PubMed ID: 19095418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
